Repare Therapeutics Inc. (RPTX): Price and Financial Metrics Recent IPO


Repare Therapeutics Inc. (RPTX) Recent IPO

Today's Latest Price: $30.02 USD

2.83 (-8.61%)

Updated Nov 24 4:00pm

Add RPTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

RPTX Stock Price Chart Interactive Chart >

Price chart for RPTX

RPTX Price/Volume Stats

Current price $30.02 52-week high $36.67
Prev. close $32.85 52-week low $21.45
Day low $29.33 Volume 137,800
Day high $32.71 Avg. volume 102,576
50-day MA $28.06 Dividend yield N/A
200-day MA $0.00 Market Cap 1.10B

Repare Therapeutics Inc. (RPTX) Company Bio


Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.


RPTX Latest News Stream


Event/Time News Detail
Loading, please wait...

RPTX Latest Social Stream


Loading social stream, please wait...

View Full RPTX Social Stream

Latest RPTX News From Around the Web

Below are the latest news stories about Repare Therapeutics Inc that investors may wish to consider to help them evaluate RPTX as an investment opportunity.

Repare Therapeutics prices upsized IPO at $20

Repare Therapeutics (RPTX) has priced its upsized IPO of 11M common shares (from 10M shares) at $20.00/share, for expected gross proceeds of ~$220M.Underwriters' over-allotment is an additional 1.65M shares. Closing date is June 23....

Seeking Alpha | June 19, 2020

Repare Therapeutics files for upsized IPO

Repare Therapeutics (RPTX) has filed a preliminary prospectus for its IPO of 10M common shares at $18 - 20 per share.Two days ago, it filed the same for an initial public offering of ~7.4M shares at $16 - 18.The Cambridge, MA-based biotech develops precision oncology treatments based on synthetic lethality...

Seeking Alpha | June 17, 2020

Read More 'RPTX' Stories Here

RPTX Price Returns

1-mo 12.73%
3-mo 27.37%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6676 seconds.